Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CAMP vs OABI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OABI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–2 Matrix Metrics)

OABI Overall Winner 6-Pillar Tally: CAMP 0 – 5 OABI (1 Tie) Matrix Metrics: CAMP 2 – 6 OABI

As of Nov 17, 2026, OmniAb, Inc. (OABI) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas OABI carries 56.2/100 (HOLD) at $5.01 (N/M Forward P/E, -92.9% operating margin).

  • Growth vs. Quality Trade-Off: OABI earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. CAMP 43.9/100 HOLD) and 1.24β · 58% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CAMP vs OABI
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol 1.34β · 94% Vol
Unified Composite Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.9 · SMA20: $3.82 · SMA50: $3.84
OABI NASDAQ Head-to-Head Winner
OmniAb, Inc. Common Stock
Services-Commercial Physical & Biological Research
$5.01
+2.45% 1D
Market Cap $716.2M
TTM Revenue $40M
Forward P/E N/M
Beta / 30D Vol 1.24β · 58% Vol
Unified Composite Score
56.2 / 100 HOLD
Tech 50.0 Fund 51.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.9% over 20 days), RSI 53
RSI-14: 52.6 · SMA20: $5.00 · SMA50: $4.77

6-Pillar Scorecard Institutional Category Breakdown (CAMP 0 – 5 OABI)

Columns: Metric · CAMP · OABI
1. Valuation Multiples OABI
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 26.6x 17.7x
2. Growth & Scale OABI
Revenue Growth (YoY) +138.9% +78.3%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $5.3M $40M
Market Cap $238.5M $716.2M
3. Profitability & Quality OABI
Gross Margin N/A 97.7%
Operating Margin -991.8% -92.9%
Net Profit Margin 0.0% -108.1%
Return on Equity (ROE) -146.1% -16.5%
4. Balance Sheet & Cash Flow OABI
Cash Generation (TTM) -$26M $2.4M
Cash Flow Margin N/A 5.9%
Net Cash / Leverage $97M Net Cash $4.7M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning OABI
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) 83.3% (10th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CAMP (2) vs OABI (6)
Institutional Metric CAMP OABI Criterion Row Edge
Market Capitalization
Scale
$238.5M $716.2M Larger Scale OABI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+138.9% +78.3% Higher Growth CAMP
Operating Margin (TTM)
Profitability
-991.8% -92.9% Higher Margin OABI
Net Profit Margin
Profitability
0.0% -108.1% Higher Margin CAMP
Return on Equity (ROE)
Capital Efficiency
-146.1% -16.5% Higher ROE OABI
52-Week Range Position
Momentum
22% ($3–$8) 89% ($1–$5) Stronger Trend OABI
Beta / 30D Volatility
Risk Regime
1.34β · 94% Vol 1.24β · 58% Vol Lower Realized Risk OABI
Unified Institutional Score
Composite Signal
43.9 / 100 (HOLD) 56.2 / 100 (HOLD) Higher Composite OABI
Trailing 12M Revenue (USD)
Operating Scale
$5.3M $40M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 97.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 26.6x EV/Rev N/M PEG · 17.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$26M ($97M Net Cash) $2.4M ($4.7M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CAMP +18.98 pp
CAMP: +25.8% · OABI: +6.82%
3M Horizon OABI +34.62 pp
CAMP: -15.05% · OABI: +19.57%
6M Horizon OABI +116.21 pp
CAMP: -4.82% · OABI: +111.39%
1Y Horizon OABI +224.81 pp
CAMP: -3.66% · OABI: +221.15%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CAMP Revenue OABI Revenue CAMP Op. Margin OABI Op. Margin Margin Leader
FY2021 N/A $30M N/A -102.5% OABI
FY2022 N/A $60M N/A -45.1% OABI
FY2023 $0M $30M -14822.6% -203.2% OABI
FY2024 $0M $30M -8142.3% -282.3% OABI
FY2025 $0M $20M -1502.4% -369.5% OABI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CAMP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
OABI SURGE
14d in phase · OBV NEUTRAL
Current IV 83.3%
IV Percentile 10th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact OABI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CAMP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
OABI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $716.2M market capitalization and -92.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CAMP vs OABI Key Questions & Quantitative Answers

As of Nov 17, 2026, OmniAb, Inc. (OABI) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas OABI carries 56.2/100 (HOLD) at $5.01 (N/M Forward P/E, -92.9% operating margin). Growth vs. Quality Trade-Off: OABI earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. CAMP 43.9/100 HOLD) and 1.24β · 58% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.

OABI leads the Growth & Scale pillar: CAMP posts +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin), compared with OABI at +78.3% YoY revenue growth and +0.0% YoY earnings growth on $40M TTM revenue (97.7% gross margin, -92.9% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), CAMP cumulative revenue shifted N/A while OABI shifted -33.3%. In operating R&D and SG&A reinvestment, CAMP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OABI.

OABI screens cheaper on headline valuation multiples. CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin), whereas OABI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 17.7x EV/Revenue (5.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CAMP (-146.1% ROE) versus OABI (-16.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk). By comparison, OABI carries 83.3% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.24β · 58% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.